![]() Real-time glucose readings sent automatically every 5 minutes to a compatible display device * No fingersticks, ¶ scanning or calibration Smaller plastic components and packaging, resulting in less waste than the Dexcom G6 CGM System 1ĭexcom G6 features included with Dexcom G7: ![]() Indicated for wear on the back of the upper arm for ages 2 years and older or the upper buttocks for ages 2-17 years old ![]() Redesigned optional receiver that is smaller, with a more vibrant, easier to read display Improved alert settings for enhanced discretion Redesigned and simplified mobile app with Dexcom Clarity integration §,|| And now that it has been cleared by the FDA, we look forward to making G7 commercially available in the coming months.”Ħ0% smaller, all-in-one, discreet † wearable, easier to use with fewer componentsģ0-minute sensor warmup, fastest of any CGM on the market ‡ġ2-hour grace period to replace finished sensors for a more seamless transition between sessions When we set out to design G7, our goal was simple: to make the most powerful, easy-to-use CGM available for people with diabetes, whether they have Type 1 or Type 2. “For more than a decade, we’ve pioneered generation after generation of sensing technology that consistently delivers improved accuracy, reliability and a simpler user experience, giving people greater control of their diabetes. “There’s a reason Dexcom has the best-selling real-time CGM on the market,” said Kevin Sayer, chairman, president and CEO of Dexcom. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the FDA has cleared the next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with all Types of diabetes ages two years and older.ĭexcom G7 now offers a more powerful and easier to use system with a small, all-in-one wearable with no fingersticks or scanning required.
0 Comments
Leave a Reply. |